Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS

• Gero P. Hooff ,

  * E-mail: g.hooff@erasmusmc.nl

  Affiliation Department of Neurology, Laboratory of Neuro-Oncology and Clinical and Cancer Proteomics, University Medical Center Rotterdam (ErasmusMC), Rotterdam, The Netherlands

  ⨯
• Nick A. van Huizen,

  Affiliation Department of Neurology, Laboratory of Neuro-Oncology and Clinical and Cancer Proteomics, University Medical Center Rotterdam (ErasmusMC), Rotterdam, The Netherlands

  ⨯
• Roland J. W. Meesters,

  Affiliation Department of Neurology, Laboratory of Neuro-Oncology and Clinical and Cancer Proteomics, University Medical Center Rotterdam (ErasmusMC), Rotterdam, The Netherlands

  ⨯
• Eduard E. Zijlstra,

  Affiliation Department of Internal Medicine, University Medical Center Rotterdam (ErasmusMC), Rotterdam, The Netherlands

  ⨯
• Mohamed Abdelraheem,

  Affiliation Department of Pediatrics and Child Health, Soba University Hospital, University of Khartoum, Alsalam Medical Centre, Khartoum, Sudan

  ⨯
• Waleed Abdelraheem,

  Affiliation Department of Pediatrics and Child Health, Soba University Hospital, University of Khartoum, Alsalam Medical Centre, Khartoum, Sudan

  ⨯
• Mohamed Hamdouk,

  Affiliation Department of Pediatrics and Child Health, Soba University Hospital, University of Khartoum, Alsalam Medical Centre, Khartoum, Sudan

  ⨯
• Jan Lindemans,

  Affiliation Department of Clinical Chemistry, University Medical Center Rotterdam (ErasmusMC), Rotterdam, The Netherlands

  ⨯
• Theo M. Luider

  Affiliation Department of Neurology, Laboratory of Neuro-Oncology and Clinical and Cancer Proteomics, University Medical Center Rotterdam (ErasmusMC), Rotterdam, The Netherlands

  ⨯